Abstract

Expansion of autoreactive follicular helper T (Tfh) cells is tightly restricted to prevent induction of autoantibody-dependent immunological diseases, such as systemic lupus erythematosus (SLE). Here we show expression of an orphan immune regulator, death receptor 6 (DR6/TNFRSF21), on a population of Tfh cells that are highly expanded in lupus-like disease progression in mice. Genome-wide screening reveals an interaction between syndecan-1 and DR6 resulting in immunosuppressive functions. Importantly, syndecan-1 is expressed specifically on autoreactive germinal centre (GC) B cells that are critical for maintenance of Tfh cells. Syndecan-1 expression level on GC B cells is associated with Tfh cell expansion and disease progression in lupus-prone mouse strains. In addition, Tfh cell suppression by DR6-specific monoclonal antibody delays disease progression in lupus-prone mice. These findings suggest that the DR6/syndecan-1 axis regulates aberrant GC reactions and could be a therapeutic target for autoimmune diseases such as SLE.

Highlights

  • Expansion of autoreactive follicular helper T (Tfh) cells is tightly restricted to prevent induction of autoantibody-dependent immunological diseases, such as systemic lupus erythematosus (SLE)

  • Recent independent studies have reported that upregulation of the TNFRSF21 gene is associated with disease prognosis by genomewide gene expression analysis using peripheral mononuclear cells obtained from SLE patients[25,26]

  • 25-1 antibody (25-1 Ab) bound DR6 stably expressed on L929 cells (L929-mDR6) (Supplementary Fig. 1a). 25-1 Abs bound to DR6, but not to other TNFRSF molecules that were expressed on the cell surface (Supplementary Fig. 1b). 25-1 Abs could bind to endogenous DR6, expressed by murine T cell hybridoma (DO11.10-T) cells (Supplementary Fig. 1c, left panel), and this reactivity was lost after Tnfrsf[21] gene-specific knockout based on the CRISPR-Cas[9] system (G510-8-7 or -10-4) (Supplementary Fig. 1c, middle and right panels), indicating that 25-1 Abs react with endogenous DR6 but not the other proteins expressed on the cell (Supplementary Fig. 1c,d)

Read more

Summary

Introduction

Expansion of autoreactive follicular helper T (Tfh) cells is tightly restricted to prevent induction of autoantibody-dependent immunological diseases, such as systemic lupus erythematosus (SLE). Tfh cell suppression by DR6-specific monoclonal antibody delays disease progression in lupus-prone mice These findings suggest that the DR6/syndecan-1 axis regulates aberrant GC reactions and could be a therapeutic target for autoimmune diseases such as SLE. A functional blockade or defect in negative costimulatory molecules, including programmed cell death 1 (PD1) or cytotoxic T-lymphocyte-associated protein 4 (CTLA4), induces an aberrant GC reaction and systemic autoimmunological disease[13,14,15,16]. These findings indicate that during T/B cell interactions, costimulatory molecules fine-tune Tfh cell differentiation, preventing the induction of systemic autoimmunity. Syndecan-1 may act as a scaffold for soluble factors, inducing the accumulation of inflammatory cells in localized inflammation[27]

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.